Goodrx Holdings, Inc. ( (GDRX) ) has released its Q1 earnings. Here is a breakdown of the information Goodrx Holdings, Inc. presented to its investors.
GoodRx Holdings, Inc. is a prominent U.S.-based platform specializing in medication savings, connecting consumers, healthcare professionals, and pharmacies to facilitate cost-effective prescription solutions.
In the first quarter of 2025, GoodRx reported revenue of $203 million, aligning with expectations, while surpassing previous guidance for its Adjusted EBITDA margin. The company maintained its full-year revenue guidance and raised its expectations for Adjusted EBITDA.
Key financial highlights include a 3% revenue increase compared to the previous year, driven by a 17% growth in pharma manufacturer solutions revenue. Despite a decrease in subscription revenue, the company achieved a net income of $11.1 million, a significant improvement from a net loss in the prior year. GoodRx also repurchased 23.3 million shares, reflecting its commitment to shareholder value.
Looking ahead, GoodRx remains optimistic about its growth prospects, with a full-year revenue forecast of $810 to $840 million and an Adjusted EBITDA target of $273 to $287 million. The company is focused on strategic initiatives to enhance its market position and deliver sustainable value across the pharmacy ecosystem.